Bridgebio Oncology Therapeutics, Inc. engages in developing bioavailable small molecule inhibitors. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
92
Frequently Asked Questions
What is Market Cap of BridgeBio Oncology Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. BridgeBio Oncology Therapeutics Inc. market cap is $541.58M.
What is the 52-week high for BridgeBio Oncology Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. BridgeBio Oncology Therapeutics Inc. 52 week high is $14.87 as of September 11, 2026.
What is the 52-week low for BridgeBio Oncology Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. BridgeBio Oncology Therapeutics Inc. 52 week low is $5.48 as of September 11, 2026.
What is BridgeBio Oncology Therapeutics Inc. stock price today?
BridgeBio Oncology Therapeutics Inc. stock price today is $5.52.
What was BridgeBio Oncology Therapeutics Inc. stock price yesterday?
BridgeBio Oncology Therapeutics Inc. stock price yesterday was $6.76.
What is the Price-to-Book ratio of BridgeBio Oncology Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. BridgeBio Oncology Therapeutics Inc. P/B ratio is 1.3687.
What is the 50-day moving average of BridgeBio Oncology Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. BridgeBio Oncology Therapeutics Inc. 50-day moving average is $8.70.
How many employees does BridgeBio Oncology Therapeutics Inc. have?
BridgeBio Oncology Therapeutics Inc. has 92 employees.